Skip to content

    TEVA PHARMACEUTICAL INDUSTRIES (TEVA) stock price & financials

    View TEVA earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance+101.9% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $4.33B
    $4.23B
    $3.89B
    $4.18B
    $4.48B
    +3.4%
    $1.50B
    -64.5%
    $3.98B
    +2.3%
    $4.14B
    -0.8%
    Weakening
    Operating Profit
    -$51.00M
    -$29.00M
    $519.00M
    $455.00M
    $882.00M
    $301.00M
    $652.00M
    +25.6%
    -$231.00M
    -150.8%
    Weakening
    Net Profit
    -$437.00M
    -$217.00M
    $214.00M
    $282.00M
    $433.00M
    $481.00M
    $369.00M
    +72.4%
    -$576.00M
    -304.3%
    Weakening
    EPS
    $-0.39
    $0.19
    $0.25
    $0.38
    $0.32
    +68.4%
    $-0.49
    -296.0%
    Weakening
    Other Income
    -$272.00M
    -$218.00M
    -$225.00M
    -$252.00M
    -$237.00M
    +12.9%
    -$220.00M
    -0.9%
    -$216.00M
    +4.0%
    -$224.00M
    +11.1%
    Strengthening
    Interest
    Depreciation
    Profit before Tax
    -$324.00M
    -$247.00M
    $294.00M
    $203.00M
    $646.00M
    $80.00M
    $437.00M
    +48.6%
    -$455.00M
    -324.1%
    Weakening
    MarginsOPM
    -1.2%
    -0.7%
    13.3%
    10.9%
    19.7%
    20.1%
    16.4%
    +22.7%
    -5.6%
    -151.2%
    Weakening
    Tax
    -21.3%
    -11.7%
    25.2%
    -38.4%
    33.1%
    -487.5%
    -4052.5%
    15.3%
    -39.1%
    -26.6%
    +30.8%
    Weakening
    ReturnsROIC
    3.1%
    1.6%
    -1.5%
    -2.0%
    -3.1%
    -199.1%
    -3.5%
    -321.7%
    -2.7%
    -72.4%
    4.1%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$1.78B$1.98B$2.18B$2.17B$2.80B$3.23B$3.30B$3.56B$3.65B
    Short-Term Investments
    Total Current Assets$13.79B$13.46B$13.01B$12.57B$12.05B$12.48B$12.55B$13.95B$13.76B
    Net PP&E$6.87B$6.95B$6.86B$6.48B$6.16B$6.15B$4.95B$4.42B$4.26B
    Goodwill$24.92B$24.85B$20.62B$17.63B$17.18B$17.18B$16.00B$16.00B$15.84B
    Intangibles$14.01B$11.23B$8.92B$7.47B$6.27B$5.39B$4.42B$3.78B$3.45B
    Total Assets$60.68B$57.47B$50.64B$47.67B$44.01B$43.48B$39.33B$40.75B$39.86B
    LiabilitiesTotal Current Liabilities$14.32B$13.67B$13.16B$11.03B$11.47B$12.25B$12.80B$13.46B$15.65B
    Short-Term Debt$2.22B$2.35B$3.19B$1.43B$2.11B$1.67B$1.78B$1.82B$4.50B
    Long-Term Debt
    Long-Term Leases$435.00M$479.00M$416.00M$349.00M$320.00M$296.00M$288.00M$282.00M
    Total Liabilities$44.89B$42.41B$39.58B$36.42B$35.41B$35.35B$33.61B$32.83B$32.10B
    EquityCommon Stock & APIC$56.00M$56.00M$57.00M$57.00M$57.00M$57.00M$58.00M$58.00M$59.00M
    Retained Earnings-$5.96B-$6.96B-$10.95B-$10.53B-$12.97B-$13.53B-$15.17B-$13.76B-$13.97B
    Total Equity$14.71B$13.97B$10.03B$10.28B$7.80B$7.51B$5.37B$7.91B$7.75B
    HighlightsNet Cash / (Debt)

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating$2.45B$748.00M$1.22B$798.00M$1.59B$1.37B$1.25B$1.65B$1.90B
    Cash from Investing$1.87B$1.35B$863.00M$1.52B$656.00M$968.00M$792.00M$737.00M$38.00M
    Cash from Financing-$3.35B-$1.93B-$1.89B-$2.17B-$1.49B-$1.91B-$1.79B-$2.15B-$401.00M
    SummaryCapital Expenditure-$651.00M-$525.00M-$578.00M-$562.00M-$548.00M-$526.00M-$498.00M-$501.00M-$550.00M
    Free Cash Flow$1.79B$223.00M$638.00M$236.00M$1.04B$842.00M$749.00M$1.15B$1.35B
    FCF Margin9.8%1.3%3.8%1.5%7.0%5.3%4.5%6.7%9.6%

    Ratios